US 8410112
Compounds useful as inhibitors of ATR kinase
granted A61KA61K31/497A61K31/541
Quick answer
US patent 8410112 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 71
- CPC classes
- A61K, A61K31/497, A61K31/541, A61K31/551, A61K45/06